Chemotherapy in non-small cell lung cancer patients after prior immunotherapy: The multicenter retrospective CLARITY study

Author:

Bersanelli Melissa,Buti Sebastiano,Giannarelli Diana,Leonetti Alessandro,Cortellini Alessio,Russo Giuseppe Lo,Signorelli Diego,Toschi Luca,Milella Michele,Pilotto Sara,Bria Emilio,Proto Claudia,Marinello Arianna,Randon Giovanni,Rossi Sabrina,Vita Emanuele,Sartori Giulia,D’Argento Ettore,Qako Eva,Giaiacopi Elisa,Ghilardi Laura,Bettini Anna Cecilia,Rapacchi Elena,Mazzoni Francesca,Lavacchi Daniele,Scotti Vieri,Ciccone Lucia Pia,De Tursi Michele,Di Marino Pietro,Santini Daniele,Russano Marco,Bordi Paola,Di Maio Massimo,Audisio Marco,Filetti Marco,Giusti Raffaele,Berardi Rossana,Fiordoliva Ilaria,Cerea Giulio,Pizzutilo Elio Gregory,Bearz Alessandra,De Carlo Elisa,Cecere Fabiana,Renna Davide,Camisa Roberta,Caruso Giuseppe,Ficorella Corrado,Banna Giuseppe Luigi,Cortinovis Diego,Brighenti Matteo,Garassino Marina Chiara,Tiseo Marcello

Funder

Seqirus and Roche S.p.A

Pfizer and Novartis

Astra Zeneca, Bristol-Myers Squibb (BMS), Novartis and Pfizer

Bristol Myers Squibb

Merck Sharp & Dohme

AstraZeneca

Janssen

Astellas

Pfizer

Eisai

Takeda

Tesaro GSK

Novartis

MSD, BMS, Boehringer (BI), Takeda, AstraZeneca

AZ, BI, Otsuka, Lilly, Novartis, MSD

MSD

BMS

Roche

AstraZeneca, Eli Lilly, Boehringer Ingelheim, Merk & Co, Roche

Eli Lilly

Boehringer Ingelheim

Otsuka Pharma

Astra Zeneca

Celgene

Incyte

Inivata

Tiziana Sciences

Clovis

Merck Serono

Bayer

GlaxoSmithKline S.p.A.

Sanofi-Aventis

Spectrum Pharmaceutcials

Blueprint Medicine

Seattle Genetics

Daiichi Sankyo

UNITED THERAPEUTICS CORPORATION

Merck KGaA

Jannesen

TURNING POINT

IPSEN

MedImmune

EXELISIS

AstraZeneca, MSD

AstraZeneca, Boehringer Ingelheim and BMS

BMS and MSD

Takeda, MSD e Roche

MSD, Astra-Zeneca, Celgene, Pfizer, Helsinn, Eli-Lilly, BMS, Novartis and Roche

Roche, Pfizer

AstraZeneca, Roche

Associazione Italiana per la Ricerca sul Cancro

Institutional funds of Università Cattolica del Sacro Cuore

Pfizer, EUSA Pharma and Astra Zeneca

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3